相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Lei Huang et al.
GUT (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial
Michele Reni et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study
Daniel Akerberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma Updates From a French Prospective Multicenter Study
Jean Robert Delpero et al.
ANNALS OF SURGERY (2017)
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
Knut J. Labori et al.
ACTA ONCOLOGICA (2016)
European cancer mortality predictions for the year 2016 with focus on leukaemias
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2016)
Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
Alexander A. Parikh et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
Xiaojuan Mi et al.
STATISTICS IN MEDICINE (2016)
The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection
Daniel J. Kagedan et al.
HPB (2016)
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis
Maikel J. Bakens et al.
CANCER MEDICINE (2016)
Danish Pancreatic Cancer Database
Claus Fristrup et al.
CLINICAL EPIDEMIOLOGY (2016)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma
Wenchuan Wu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The Danish Civil Registration System as a tool in epidemiology
Morten Schmidt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
Juan W. Valle et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection
Yoshiaki Murakami et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Performance status of patients is the major prognostic factor at all stages of pancreatic cancer
Faruk Tas et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Resection Margins in Pancreatic Cancer
Caroline S. Verbeke
SURGICAL CLINICS OF NORTH AMERICA (2013)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
NORDCAN - a Nordic tool for cancer information, planning, quality control and research
Gerda Engholm et al.
ACTA ONCOLOGICA (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
H. Ueno et al.
BRITISH JOURNAL OF CANCER (2009)
Benefit of Postoperative Adjuvant Therapy for Pancreatic Cancer A Population-based Analysis
Kimberly A. Vanderveen et al.
CANCER (2009)
Clinical Trial Enrollment, Patient Characteristics, and Survival Differences in Prospectively Registered Metastatic Colorectal Cancer Patients
Halfdan Sorbye et al.
CANCER (2009)
The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer
Hartwig Riediger et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Hospital volume and mortality after pancreatic resection - A systematic review and an evaluation of intervention in The Netherlands
NT van Heek et al.
ANNALS OF SURGERY (2005)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
JP Neoptolemos et al.
LANCET (2001)
分享论文
